Is ASCBR or JNJ a better dividend investment in 2026?

ASCBR currently yields 2624.67% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ASCBR offers higher current income.

What is the dividend yield difference between ASCBR and JNJ?

ASCBR has a forward dividend yield of 2624.67% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2621.31 percentage points.

Home › Compare › ASCBR vs JNJ

ASCBR vs JNJ: Dividend Comparison 2026

ASCBR yields 2624.67% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ASCBR wins by $127710608712.85M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ASCBR

● Live price

2624.67%

Share price

$0.08

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$127710608712.87M

Annual income

$118,806,261,572,163,740.00

Full ASCBR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ASCBR vs JNJ

📍 ASCBR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ASCBR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ASCBR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ASCBR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASCBR

Annual income on $10K today (after 15% tax)

$223,097.11/yr

After 10yr DRIP, annual income (after tax)

$100,985,322,336,339,180.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ASCBR beats the other by $100,985,322,336,338,480.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASCBR + JNJ for your $10,000?

ASCBR: 50%JNJ: 50%

100% JNJ50/50100% ASCBR

Portfolio after 10yr

$63855304356.44M

Annual income

$59,403,130,786,082,290.00/yr

Blended yield

93.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASCBR

No analyst data

Altman Z

-15.8

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASCBR buys

JNJ buys

No recent congressional trades found for ASCBR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricASCBRJNJ

Forward yield	2624.67% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$127710608712.87M ✓	$20.0K
Annual income after 10y	$118,806,261,572,163,740.00 ✓	$827.78
Total dividends collected	$127090281180.79M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ASCBR vs JNJ ($10,000, DRIP)

Year	ASCBR Portfolio	ASCBR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$273,167	$262,467.19	$10,676	$355.77	+$262.5K → ASCBR
2	$6,992,983	$6,700,693.98	$11,407	$389.39	+$6.98M → ASCBR
3	$167,795,932	$160,313,440.20	$12,198	$426.53	+$167.78M → ASCBR
4	$3,774,593,168	$3,595,051,520.90	$13,056	$467.62	+$3774.58M → ASCBR
5	$79,619,367,322	$75,580,552,632.68	$13,987	$513.12	+$79619.35M → ASCBR
6	$1,575,153,576,582	$1,489,960,853,547.05	$14,998	$563.56	+$1575153.56M → ASCBR
7	$29,233,743,383,957	$27,548,329,057,013.89	$16,098	$619.52	+$29233743.37M → ASCBR
8	$509,109,663,076,461	$477,829,557,655,627.25	$17,295	$681.69	+$509109663.06M → ASCBR
9	$8,321,819,757,668,696	$7,777,072,418,176,883.00	$18,599	$750.82	+$8321819757.65M → ASCBR
10	$127,710,608,712,869,260	$118,806,261,572,163,740.00	$20,022	$827.78	+$127710608712.85M → ASCBR

ASCBR vs JNJ: Complete Analysis 2026

ASCBR — Stock

A SPAC II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corp. operates as a subsidiary of A SPAC II (Holdings) Corp.

Full ASCBR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ASCBR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASCBR vs SCHD ASCBR vs JEPI ASCBR vs O ASCBR vs KO ASCBR vs MAIN ASCBR vs ABBV ASCBR vs MRK ASCBR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.